Furthermore, in patients with suspected autoimmune diseases, higher isolated positive serum anti-TRIM21/Ro52 antibodies are associated with a higher diagnostic rate of immunologic disorders and malignancies as compared with the anti-Ro52 and anti-Ro60 double-positive population [39]. The gene discussed is TRIM21; the disease is autoimmune disease.